Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Gross Margin: 2024-2025

Historic Gross Margin for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to 100.00%.

  • Kura Oncology's Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Kura Oncology's Gross Margin stood at 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Kura Oncology's 5-year Gross Margin high stood at 100.00% for Q1 2024, and its period low was 100.00% during Q1 2024.
  • Over the past 2 years, Kura Oncology's median Gross Margin value was 100.00% (recorded in 2025), while the average stood at 100.00%.